Dendreon Corp. (extinct)

Dendreon Corp. (extinct)

Dendreon Corp. (extinct)

Overview
Date Founded

1992

Headquarters

1208 Eastlake Avenue East,Seattle, WA 98102

Type of Company

Private

Employees (Worldwide)

1,001 - 5,000

Industries

Pharmaceuticals
Biotechnology
Medical Products & Equipment
Hospitals & Patient Services

Company Description

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

Contact Data
Trying to get in touch with decision makers at Dendreon Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Dendreon Corp.
Potential Connections via
Relationship Science
You
Dendreon Corp.
Recent Transactions
Details Hidden

Bausch Health Cos., Inc. purchases Dendreon Corp.

Details Hidden

Dendreon Corp. issued Common Stock

Details Hidden

Dendreon Corp. issued Common Stock

Transaction Advisors
Investment Advisor

Advised onDendreon Corp. purchases Corvas International, Inc.

Underwriter

Advised onDendreon Corp. issued Common Stock

Underwriter

Advised onDendreon Corp. issued Common Stock

Legal Advisor

Advised onBausch Health Cos., Inc. purchases Dendreon Corp.

Legal Advisor

Advised onBausch Health Cos., Inc. purchases Dendreon Corp.

Legal Advisor

Advised onDendreon Corp. issued Common Stock

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Jones Day

Legal Advisor

Former Of Counsel at Wilson Sonsini Goodrich & Rosati PC

Key Stats and Financials As of
Market Capitalization
$5.79M
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
$25K - $50K
2013
$1 - $999
2012
$50K - $100K
2010
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dendreon Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dendreon Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Dendreon Corp..